10 studies on Matrixyl curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
Manufacturers with published third-party certificates of analysis for Matrixyl. Open a vendor to see every batch we've verified.
This research provides crucial insights for the rational design of peptide-based cosmetic ingredients, particularly those targeting **collagen stimulation**. Understanding how subtle changes in peptide sequence (e.g.,…
This study highlights the potential of carnosine-derived lipidated peptides as a new class of biomaterials with inherent therapeutic properties. The ability to form tunable hydrogels means CLP could serve as a self-de…
The study yielded compelling results, demonstrating that AAH exhibited significantly lower toxicity in HaCaT cells compared to the positive control, matrixyl, with cell viability remaining robust at 81.52% for AAH-tre…
This research highlights Thêta-Cream as a potentially superior prophylactic agent for managing radiation dermatitis in breast cancer patients, offering a significant improvement over existing standard care. Its abilit…
This study highlights the exciting potential of repurposing peptides with established functions, like collagenesis induction, into novel antimicrobial agents. The demonstrated efficacy against multidrug-resistant Gram…
This research highlights the powerful potential of combining i-PRF with bioactive peptides for regenerative applications in dermatology. The observed synergy suggests a novel approach to enhance skin rejuvenation, imp…
Free, no account — handy when you're working with Matrixyl.